Cervical cancer is the fourth most common cancer among women. Infection by high-risk
human papillomavirus (HPV) is the main aetiology for the development of cervical cancer …

Cervical cancer is the second most common cancer in women worldwide, and knowledge
regarding its cause and pathogenesis is expanding rapidly. Persistent infection with one of …

This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

This essay summarizes my views on (a) the foundations of portfolio theory and its
applications to current issues, such as the choice of criteria for practical risk-return analysis …

Worldwide human papillomavirus (HPV) prevalence in women with normal cytology at any
given point in time is approximately 10% indicating that HPV is one of the most common …

Background: Previous analyses from a randomised trial in women aged 24–45 years have
shown the quadrivalent human papillomavirus (qHPV) vaccine to be efficacious in the …

Objective To obtain large scale and generalisable data on the long term predictive value of
cytology and human papillomavirus (HPV) testing for development of cervical intraepithelial …

BACKGROUND: Combined oral contraceptives are classified by the International Agency for
Research on Cancer as a cause of cervical cancer. As the incidence of cervical cancer …

The immune system uses innate and adaptive immunity to recognize and combat foreign
agents that invade the body, but these methods are sometimes ineffective against human …

Certain sexually transmitted human papillomavirus (HPV) types are causally associated with
the development of cervical cancer. Our recent development of high-titer HPV …